gopubmed logo
 
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 08 Dec 2016.

Ribosomal L24 domain containing 1

L30, RP29
This gene encodes a protein sharing a low level of sequence similarity with human ribosomal protein L24. Although this gene has been referred to as RPL24, L30, and 60S ribosomal protein L30 isolog in the sequence databases, it is distinct from the human genes officially named RPL24 (which itself has been referred to as ribosomal protein L30) and RPL30. The function of this gene is currently unknown. This gene utilizes alternative polyadenylation signals. [provided by RefSeq, Jul 2008] (from NCBI)
Top mentioned proteins: RANK, POLYMERASE, OUT, AGE, Rhodopsin
Papers on L30
Gene expression in the mouse eye: an online resource for genetics using 103 strains of mice.
Williams et al., Memphis, United States. In Mol Vis, 2008
We demonstrate that variation in rhodopsin expression efficiently predicts candidate genes for eight uncloned retinal diseases, including WDR17 for the human RP29 locus.
Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes.
Jouzeau et al., Vandœuvre-lès-Nancy, France. In Osteoarthritis Cartilage, 2007
Levels of mRNA for PPAR target genes [acyl-CoA oxidase (ACO) for PPARalpha; mitochondrial carnitin palmitoyl transferase-1 (CPT-1) for PPARbeta/delta and adiponectin for PPARgamma], aggrecan, TGF-beta1 and genes controlling GAGs' side chains' synthesis were quantified by real time polymerase chain reaction and normalized over RP29 housekeeping gene.
Polyelectrolyte complexes of Eudragit l30 d-55 and gelatin: antinociceptive activity of entrapped piroxicam.
Attama, Enugu, Nigeria. In Drug Deliv, 2007
In this study, in vitro and in vivo studies were carried out on polyelectolyte complexes formulated with Eudragit L30 D-55 and gelatin.
In silico characterisation and chromosomal localisation of human RRH (peropsin)--implications for opsin evolution.
Foster et al., London, United Kingdom. In Bmc Genomics, 2003
RESULTS: By in silico analysis of the GenBank database we have determined that the human RRH comprises 7 exons spanning approximately 16.5 kb and is localised to chromosome 4q25 in the following gene sequence: cen-EGF-RRH-IF-qter - a position that excludes this gene as a candidate for the RP29 autosomal recessive retinitis pigmentosa locus.
Cloning and characterization of WDR17, a novel WD repeat-containing gene on chromosome 4q34.
Weber et al., Würzburg, Germany. In Biochim Biophys Acta, 2002
Human WDR17 maps to the same chromosomal interval as the locus for autosomal recessive retinitis pigmentosa (RP29) on 4q34, making it a candidate for this disease gene.
The National Blindness and Low Vision Prevalence Survey of Bangladesh: research design, eye examination methodology and results of the pilot study.
Johnson et al., London, United Kingdom. In Ophthalmic Epidemiol, 2002
Multi-stage stratified (rural/urban) cluster random sampling, with probability proportional-to-size procedures, will be used for selection of a cross-sectional, nationally representative sample (12,900 subjects) of the population aged > or = l30 years.
A new locus for autosomal recessive RP (RP29) mapping to chromosome 4q32-q34 in a Pakistani family.
Bhattacharya et al., Islamabad, Pakistan. In Invest Ophthalmol Vis Sci, 2001
RESULTS: A new locus for arRP (RP29) has been mapped to chromosome 4q32-q34.
A novel genetic screen for snRNP assembly factors in yeast identifies a conserved protein, Sad1p, also required for pre-mRNA splicing.
Séraphin et al., Heidelberg, Germany. In Mol Cell Biol, 1999
In addition to having the snRNP assembly defect, the sad1-1 mutant is severely impaired in splicing at the restrictive temperature: the RP29 pre-mRNA strongly accumulates and splicing-dependent production of beta-galactosidase from reporter constructs is abolished, while extracts prepared from sad1-1 strains fail to splice pre-mRNA substrates in vitro.
Nucleotide sequence of a Dictyostelium discoideum gene encoding a protein homologous to the yeast ribosomal protein S31.
Dingermann et al., Nürnberg, Germany. In Biochem Biophys Res Commun, 1993
The intron carries a CAATCAAT motif which has been described as inducer element for discoidin I gamma expression and which has also been found within the intron of the rp29 gene form D. discoideum.
Screening a yeast promoter library leads to the isolation of the RP29/L32 and SNR17B/RPL37A divergent promoters and the discovery of a gene encoding ribosomal protein L37.
Moldave et al., Hattiesburg, United States. In Gene, 1991
Two promoters (A7 and A23), isolated at random from the Saccharomyces cerevisiae genome by virtue of their capacity to activate transcription, are identical to known intergenic bidirectional promoters.
A developmentally regulated gene encodes the dictyostelium homolog of yeast ribosomal protein S4 and mammalian LLRep3 proteins.
Hames et al., Leeds, United Kingdom. In Nucleic Acids Res, 1991
The Dictyostelium gene encodes a polypeptide 28,717 Da in size and hence this ribosomal protein has been named rp29.
The yeast ribosomal protein L32 and its gene.
Warner et al., New York City, United States. In J Biol Chem, 1987
The yeast ribosomal protein gene RPL32 of Saccharomyces cerevisiae is of particular interest for two reasons: 1) it is adjacent to another ribosomal protein gene, RP29, whose divergent transcription may be driven from the same control sequences, and 2) it appears that the splicing of its transcript is regulated by the product of the gene, ribosomal protein in L32.
A yeast ribosomal protein gene whose intron is in the 5' leader.
Warner et al., In J Biol Chem, 1984
The coordinates of transcription initiation and termination of the rp29 gene have been mapped.
Establishment of lymphoblastoid cell lines from Marek's disease primary tumors.
Nazerian et al., In Poult Sci, 1983
These cell lines are designated as MDCC-RP22 through MDCC-RP29.
Borderline hypertension.
Julius et al., In Prim Care, 1983
We cannot currently recommend pharmacologic therapy for the vast majority of patients with blood pressures between l30/80 and l140/90 mm Hg.
share on facebooktweetadd +1mail to friends